This dividend stock has raised its payout for 49 years and now yields 5.5%!

A small-cap dividend stock with a cracking long-term dividend record and a healthy forecast yield — what’s not to like about that?

| More on:
British coins and bank notes scattered on a surface

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

A stock that’s raised its annual dividend for 49 years in a row has got to be a good passive income pick, right? Well, it can depend on the dividend yield. So what if I say there’s such a stock out there whose share price has dropped and pushed the forecast yield up to 5.5%?

That’s the picture I’m seeing when I look at James Halstead (LSE: JHD), after a 38% share price fall in the past five years. But a fallen share price isn’t a good thing. It depends on the reason, and whether it’s something that could halt those dividend rises.

Anything wrong?

James Halstead is in the thoroughly unexciting business of industrial flooring. And it looks like it’s something of a market leader. With some of its products used in hospitals to the exclusion of competitors, I see a bit of a defensive moat.

The recent share price weakness has come since early 2022. That’s been a period of high inflation and interest rates, and a very shaky economic outlook. For the year ended June 2024, the company reported a 9.4% fall in revenue.

But that softened to a bottom-line 2% fall in earnings per share (EPS) to 10p. And it was still enough to cover the 8.5p full-year dividend. It’s not strong cover, but in a business downturn, seeing anything positive is good.

The company was rightly proud of its “unbroken chain of dividend payment increases from 1974.”

Looking up

By the current financial year’s halfway point at 31 December 2024, we saw a 4.7% decline in revenue from the same period a year previously. That’s slowing, and EPS actually rose to 5p in the half. The interim dividend? Up again, by 10% to a record 2.75p per share. We could be on for 50 years.

Executive Chairman Mark Halstead spoke of a “backdrop of difficult markets” and “short-term confidence weakness in Europe.” But he also reported “raised profits underpinned by improved margins and reductions in overheads.

Oh, and note his name. I do like it when a company’s founding family is still at the helm.

Risky business?

A few things mean caution is needed here. We’re looking at a forecast price-to-earnings (P/E) multiple of 15, which isn’t an obviously screaming cheap valuation. And with the company listed on the Alternative Investment Market (AIM), it doesn’t attract many analysts.

In fact, I can find only two offering recommendations, one Buy and one Hold. Still, there’s an average share price target on the stock of 300p. At the time of writing, James Halstead shares are selling for 159p. That’s a healthy growth expectation.

Dividend cover is a bit thin. And if it’s not enough one year to lift the dividend yet again, I could see a share price slump. And we’re not out of the economic woods yet.

On balance, I’d say the revenue and share price weakness has been due to cyclical economic issues. And I see no fundamental problem with the company itself. It’s on my list of passive income stocks to consider for my ISA.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Growth Shares

This FTSE 250 stock has beaten the index by around 10x over the last year

Jon Smith rates a FTSE 250 stock that has smashed the broader index performance and could keep going based on…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

B&M shares are at record lows! Is now the time to consider buying?

The retailer, demoted from the FTSE 100 to the FTSE 250 last year, continues to struggle. But are B&M shares…

Read more »

Investing For Beginners

2 reasons why the stock market could hit 10,000 points by December

Jon Smith explains how the makeup of the UK stock market and the current valuation could support a move towards…

Read more »

Queen Street, one of Cardiff's main shopping streets, busy with Saturday shoppers.
Investing Articles

Why this FTSE 100 rocket is this investment trust’s number 1 holding

A UK investment trust is certainly going against the grain by having this FTSE 100 share as a high-conviction holding…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

These 2 FTSE growth stocks jumped 8% and 4.5% today!

Ben McPoland takes a closer look at a pair of FTSE stocks that are performing really well recently. Why are…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

This under‑the‑radar FTSE 100 growth stock is also a secret dividend superstar!

Harvey Jones belatedly wakes up to a brilliant FTSE 100 growth stock that has an equally remarkable track record of…

Read more »

Business manager working at a pub doing the accountancy and some paperwork using a laptop computer
Investing Articles

Barratt Redrow share price plunges 9% on profits hit – time to consider buying?

Harvey Jones says FTSE 100 housebuilders continue to suffer with the Barratt Redrow share price slumping on a profit warning.…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Growth Shares

Why the next month could make or break the Lloyds share price

Jon Smith outlines two key events in coming weeks that could influence the Lloyds share price, leading him to make…

Read more »